Navigation Links
FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
Date:3/11/2010

Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release. For example, any statements in this press release concerning future approvals or other events related to products or future products and Watson's strategic initiatives and business plans are forward-looking statements. It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the impact of competitive products and pricing; timely and successful consummation and implementation of strategic initiatives; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and FDA or other regulatory agency approvals or actions; costs and efforts to defend or enforce intellectual property and contractual rights; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson their third party manufacturers' facilities, products and/or businesses; changes in the laws and regulations, including Medicare and Medicaid, affecting among other things, pricing and reimbursement of pharmaceutical products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's annual report on Form 10-K for the year ended December 31, 2009. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Name Change for Heartburn Drug Kapidex
2. FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
3. FDA Approves First New Inhaled Antibiotic for CF in More Than a Decade
4. FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinsons Disease
5. FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
6. FDA Approves Xiaflex for Debilitating Hand Condition
7. FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
8. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
9. FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
10. FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older
11. FDA Approves Lillys ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Pa. , May 20, 2013  B. ... patient, clinician and environmental safety with products, services ... B.Braun will feature its innovative Outlook® 400ES and ... and barcoding capabilities at the American Association of ... at the Boston Convention ...
(Date:5/20/2013)... , May 20, 2013  Valeant Pharmaceuticals International, Inc. (NYSE: ... its senior management team will make a presentation at the ... June 11, 2013 at 9:20 a.m. PT. The conference will ... Angeles, CA. A live webcast and ... company,s Web site at www.valeant.com . Click on Investor ...
(Date:5/20/2013)... BATESVILLE, Ind. , May 20, 2013  Hill-Rom ... to listen to a management presentation at the 38 ... Boston on May 30, 2013, ... ) You are invited to listen ... http://ir.hill-rom.com/events.cfm or access it directly at ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2
... 2011 ARKRAY announced today that it has been ... the group purchasing unit of the Premier healthcare alliance, ... all Premier Continuum of Care members, at their discretion, ... by Premier for ARKRAY,s Blood Glucose Meters and Reagents, ...
... Inc. today announced that it has completed patient enrollment ... the MiStent® Drug-Eluting Coronary Stent System. The MiStent DES ... drug/polymer coating formulation. Enrollment of 183 patients across 26 ... ahead of schedule. Micell previously announced that, ...
Cached Medicine Technology:ARKRAY Awarded Blood Glucose Meters Agreement With the Premier Healthcare Alliance for Non-Acute Members 2Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent 2Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent 3
(Date:5/21/2013)... The National Resident Matching Program NRMP® ... its Board of Directors. Hal B. Jenson, M.D., ... of Medicine, has been named President. Maria C. ... of California San Diego, is the President-Designate, and Glenn ... Medical Center, is the Secretary-Treasurer. Kenneth B. Simons, ...
(Date:5/21/2013)... Dr. James C. Wittig, Chief of ... Sarcoma Division of the John Theurer Cancer Center at ... named one of the top 13 Orthopedic Oncologists in ... Wittig is one of approximately 125 surgeons in America ... by surveying thought leaders in the field of Oncology. ...
(Date:5/21/2013)... 21, 2013 Brunswick Laboratories, Inc. ... the development and standardization of validated analytical methods, ... Brunswick Laboratories and the USDA, as a First ... This decision comes after extensive review by an ... Harnly of the U.S. Department of Agriculture. , ...
(Date:5/21/2013)... According to the Center for Disease Control and ... year. Over 800,000 of these bites require medical attention, ... should be aware of the danger that dog bites pose ... and children may sustain more serious injuries than an adult. ... the ages of 5 and 9 are at the greatest ...
(Date:5/20/2013)... USA Book News announced Monday that "The ... won the top honor in its 2013 International Book ... multitude of international titles published from 2011-2013, "The Infinity ... both mainstream and new age audiences looking to improve ... , “The Infinity Zone” is a phenomenon ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3
... Eat Right, Move More and ... Milk Their Diets, DENVER, June 5 ... fad diets -- which seem to go in and out of,fashion like shoulder ... remain overweight or obese., A new campaign crossing the country, the Campaign ...
... ATLANTA, June 5 Elekta, a world class ... selected to supply,multiple Elekta Synergy(R) digital linear accelerator ... next few years., The new Elekta Synergy ... Radiation Therapy (IGRT), which Mary Bird Perkins,(MBP) began ...
... Fever for an evening of celebration, INDIANAPOLIS, June 5 ... honored by the March of Dimes on June 7 at ... help families,with critically ill babies throughout the state and to ... For several years, Anthem has teamed up with the March ...
... Coalition warns patients about injections on vacation ... YORK, June 5 The Physicians Coalition,for ... worldwide of the dangers of accepting Botox(R), ... from unfamiliar physicians during,vacation, cruise or spa ...
... watching a small group of neurons that enable sexual maturity ... near the developing nose, to deep inside the brain. ... the zebrafish will help explain why some neurons don,t make ... sexually mature as a result. , "They can go ...
... University researcher Bess Dawson-Hughes, M.D., chaired the ... Foundation (NOF) Clinician,s Guide to Prevention and ... Guide incorporates the World Health Organization (WHO) ... tool expected to increase the identification of ...
Cached Medicine News:Health News:Message to Denver Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Denver Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Message to Denver Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 4Health News:Elekta and Mary Bird Perkins Cancer Center Sign Strategic Multi-Center Radiation Therapy Systems Agreement 2Health News:Elekta and Mary Bird Perkins Cancer Center Sign Strategic Multi-Center Radiation Therapy Systems Agreement 3Health News:Anthem Blue Cross and Blue Shield Honored by March of Dimes 2Health News:Botox and Restylane Not A Destination or Spa Treatment 2Health News:Botox and Restylane Not A Destination or Spa Treatment 3Health News:Botox and Restylane Not A Destination or Spa Treatment 4Health News:Zebrafish enable scientists to study the migration of neurons that enable sexual maturity 2Health News:Zebrafish enable scientists to study the migration of neurons that enable sexual maturity 3Health News:Tufts researcher leads revision of osteoporosis guidelines 2Health News:Tufts researcher leads revision of osteoporosis guidelines 3
SofLens Multi-Focal with unique Natra-Sight Optics designed to provide broad transition for near, intermediate and far vision, SofLens Multi-Focal lenses offer crisp, clear vision at all distances....
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
Bausch & Lomb SofLens59 contact lenses combine excellent performance, comfort and visual acuity providing daily wear for two week replacement....
... uses reflection mirrors to measure the ... after tumor removal or thyroid decompression. ... Naugle is easy to handle- with ... and plastic mounts that are placed ...
Medicine Products: